Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Manuel Penichet
University of California Los Angeles, Department: Surgery
Should you be removed from our database? Contact us at [email protected]. Read more below.
Klyss Biotech, Inc
Intellectual property rights (e.g., royalties, patents, copyrights) not from the awardee Institution
Professor Penichet is the principal investigator. He is a consultant, founder, board member and expert scientist for the company. He owns (b)(4) of the company stock.
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL
We have developed two antibodies, ch128.1 and ch128.1Av that have shown promising results as a potential treatment for blood cancers; importantly, ch128.1Av can be loaded with other anti-cancer agents that can act as 'warheads' to increase its anti-cancer efficacy. The main goals of the present proposal are to understand how ch128.1Av and ch128.1, alone or in combination with other drugs, can be used to prevent and/or treat AIDS-associated lymphoma, as well as how these antibodies can be used to fight the growth of these devastating cancers. It is expected that our multifaceted strategy will contribute to a reduction of the human and economic cost caused by these AIDS-associated cancers and potentially other malignancies.
Filed on January 26, 2016.
Tell us what you know about Manuel Penichet's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Manuel Penichet filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Manuel Penichet | University of California Los Angeles | Conflict of Interest | Klyss Biotech, Inc | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.